Zoledronic acid is an adjuvant treatment for primary osteosarcoma. Zoledronic acid has been widely used in the treatment of metastatic bone tumors. In addition to its inhibition of tumor osteoclasis, it also produces certain killing of tumor cells. effect. Foreign studies have shown that zoledronic acid also has a killing effect on osteosarcoma and has a certain inhibitory effect on distant metastasis. We hope that it can reduce tumor recurrence and lung metastasis through this study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
150
2nd Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China
RECRUITINGrate of lung metastasis
Discovery the rate of neonatal lung metastases by high-resolution chest CT
Time frame: 3 year
rate of tumor recurrence
Local recurrence rate of tumor or rate of distant metastasis
Time frame: 3 year
rate of tumor necrosis less than 90%
the rate of patients that postoperative tumor necrosis rate was estimated to be lower than grade III(90%)
Time frame: 3 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.